Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of “Hold” by Analysts

Shares of Pediatrix Medical Group, Inc. (NYSE:MDGet Rating) have been assigned an average recommendation of “Hold” from the eight ratings firms that are presently covering the stock, MarketBeat reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $19.00.

MD has been the subject of several recent analyst reports. Credit Suisse Group decreased their target price on Pediatrix Medical Group from $27.00 to $23.00 and set an “outperform” rating for the company in a research note on Wednesday, February 22nd. StockNews.com started coverage on Pediatrix Medical Group in a research report on Thursday. They set a “hold” rating on the stock.

Hedge Funds Weigh In On Pediatrix Medical Group

A number of institutional investors and hedge funds have recently bought and sold shares of MD. Eagle Bay Advisors LLC boosted its holdings in Pediatrix Medical Group by 122.5% during the second quarter. Eagle Bay Advisors LLC now owns 1,595 shares of the company’s stock worth $34,000 after buying an additional 878 shares during the last quarter. Royal Bank of Canada grew its position in Pediatrix Medical Group by 97.3% in the third quarter. Royal Bank of Canada now owns 2,166 shares of the company’s stock valued at $35,000 after purchasing an additional 1,068 shares in the last quarter. Wipfli Financial Advisors LLC bought a new position in shares of Pediatrix Medical Group in the 3rd quarter valued at about $37,000. Sargent Bickham Lagudis LLC bought a new stake in shares of Pediatrix Medical Group in the 3rd quarter valued at about $38,000. Finally, Point72 Hong Kong Ltd acquired a new position in shares of Pediatrix Medical Group during the 3rd quarter worth approximately $43,000. Institutional investors and hedge funds own 95.99% of the company’s stock.

Pediatrix Medical Group Stock Up 1.0 %

Pediatrix Medical Group stock opened at $14.14 on Friday. The firm has a market cap of $1.17 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 2.19 and a beta of 1.75. The firm has a fifty day moving average price of $15.37 and a two-hundred day moving average price of $16.15. Pediatrix Medical Group has a fifty-two week low of $13.66 and a fifty-two week high of $24.67. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.00 and a quick ratio of 1.00.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc engages in the provision of physician services. It includes newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

Further Reading

Analyst Recommendations for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.